Search This Blog

Wednesday, August 19, 2026

Aurinia, Teva settle LUPKYNIS patent suit

 

Aurinia, Teva settle LUPKYNIS patent suit as Teva admits infringement, delays U.S. generic launch until Dec. 7, 2036, absent limited contingencies

  • Settlement establishes agreed U.S. launch terms for Teva’s generic voclosporin product.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)